Fatal relapse of disseminated strongyloidiasis in an HIV-positive patient, despite ivermectin treatment.
Ann Trop Med Parasitol
; 102(8): 693-8, 2008 Dec.
Article
en En
| MEDLINE
| ID: mdl-19000386
ABSTRACT
There are no established guidelines for the treatment of disseminated strongyloidiasis in immunosuppressed patients, and many different treatment regimens have been used. Here, the case of a 48-year-old, HIV-positive, Congolese man, who was hospitalized for disseminated tuberculosis but developed life-threatening disseminated strongyloidiasis, is described. This patient died, with relapsing disseminated strongyloidiasis, 3 months after being treated with ivermectin. The reasons for this poor outcome and the various treatment options for strongyloidiasis in HIV-infected patients are discussed.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Estrongiloidiasis
/
Ivermectina
/
Seropositividad para VIH
/
Strongyloides stercoralis
/
Enfermedades Pulmonares Parasitarias
/
Antinematodos
Tipo de estudio:
Guideline
Límite:
Animals
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ann Trop Med Parasitol
Año:
2008
Tipo del documento:
Article
País de afiliación:
Francia